Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Merli

Showing results (71-80 of 117) with videos related to

Pageof 12
Sort By:
British Journal of Haematology|November 28, 2024
Efficacy and safety of bendamustine, rituximab and bortezomib treatment in relapsed/refractory Waldenstrom Macroglobulinaemia: results of phase 2 single-arm FIL-BRB trialGiulia Benevolo, Daniela Drandi, Nicoletta Villivà, et al.
Haematologica|May 12, 2018
Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the <i>Fondazione Italiana Linfomi</i>Sergio Storti, Michele Spina, Emanuela Anna Pesce, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2022
Direct-Acting Antivirals as Primary Treatment for Hepatitis C Virus-Associated Indolent Non-Hodgkin Lymphomas: The BArT Study of the Fondazione Italiana LinfomiMichele Merli, Sara Rattotti, Michele Spina, et al.
Blood|July 12, 2019
Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 studyStefano Luminari, Michele Merli, Sara Rattotti, et al.
British Journal of Haematology|February 3, 2023
Biological features and outcome of diffuse large B-cell lymphoma associated with hepatitis C virus in elderly patients: Results of the prospective 'Elderly Project' by the Fondazione Italiana LinfomiAnnalisa Arcari, Valentina Tabanelli, Francesco Merli, et al.
Blood|September 9, 2016
Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infectionLuca Arcaini, Caroline Besson, Marco Frigeni, et al.
Nature Communications|June 8, 2018
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hubRocco Piazza, Vera Magistroni, Sara Redaelli, et al.
Leukemia & Lymphoma|January 11, 2025
Interim-PET predicts progression-free survival in stage IV Hodgkin lymphoma treated with upfront brentuximab vedotin-AVDChiara Rusconi, Angelica Barone, Andrea Visentin, et al.
British Journal of Haematology|March 5, 2024
Molecular characterization of diffuse large B-cell lymphomas associated with hepatitis C virus infectionRoberta Sciarra, Michele Merli, Caterina Cristinelli, et al.
British Journal of Haematology|March 9, 2026
Renal dysfunction in symptomatic Waldenström macroglobulinaemia: A nationwide Italian multicentre studyNicolò Danesin, Francesco Autore, Anna Maria Frustaci, et al.
Pageof 12

Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
British Journal of Haematology|November 28, 2024
Efficacy and safety of bendamustine, rituximab and bortezomib treatment in relapsed/refractory Waldenstrom Macroglobulinaemia: results of phase 2 single-arm FIL-BRB trialGiulia Benevolo, Daniela Drandi, Nicoletta Villivà, et al.
Haematologica|May 12, 2018
Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the <i>Fondazione Italiana Linfomi</i>Sergio Storti, Michele Spina, Emanuela Anna Pesce, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2022
Direct-Acting Antivirals as Primary Treatment for Hepatitis C Virus-Associated Indolent Non-Hodgkin Lymphomas: The BArT Study of the Fondazione Italiana LinfomiMichele Merli, Sara Rattotti, Michele Spina, et al.
Blood|July 12, 2019
Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 studyStefano Luminari, Michele Merli, Sara Rattotti, et al.
British Journal of Haematology|February 3, 2023
Biological features and outcome of diffuse large B-cell lymphoma associated with hepatitis C virus in elderly patients: Results of the prospective 'Elderly Project' by the Fondazione Italiana LinfomiAnnalisa Arcari, Valentina Tabanelli, Francesco Merli, et al.
Blood|September 9, 2016
Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infectionLuca Arcaini, Caroline Besson, Marco Frigeni, et al.
Nature Communications|June 8, 2018
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hubRocco Piazza, Vera Magistroni, Sara Redaelli, et al.
Leukemia & Lymphoma|January 11, 2025
Interim-PET predicts progression-free survival in stage IV Hodgkin lymphoma treated with upfront brentuximab vedotin-AVDChiara Rusconi, Angelica Barone, Andrea Visentin, et al.
British Journal of Haematology|March 5, 2024
Molecular characterization of diffuse large B-cell lymphomas associated with hepatitis C virus infectionRoberta Sciarra, Michele Merli, Caterina Cristinelli, et al.
British Journal of Haematology|March 9, 2026
Renal dysfunction in symptomatic Waldenström macroglobulinaemia: A nationwide Italian multicentre studyNicolò Danesin, Francesco Autore, Anna Maria Frustaci, et al.
Pageof 12